QuidelOrtho Corporation
General ticker "QDEL" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $2.2B (TTM average)
QuidelOrtho Corporation follows the US Stock Market performance with the rate: 5.5%.
Estimated limits based on current volatility of 2.8%: low 21.16$, high 22.39$
Factors to consider:
- Total employees count: 6600 as of 2024
- US accounted for 56.4% of revenue in the fiscal year ended 2024-12-29
- Top business risk factors: Market competition, Failure to innovate, Geopolitical risks, Respiratory product sales fluctuations, Supply chain disruptions
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-28 to 2027-12-28
- 2025-12-28 to 2026-12-28 estimated range: [18.47$, 36.68$]
- 2026-12-28 to 2027-12-28 estimated range: [17.16$, 34.45$]
Short-term QDEL quotes
Long-term QDEL plot with estimates
Financial data
| YTD | 2025-12-28 |
|---|---|
| Operating Revenue | $2,730.20MM |
| Operating Expenses | $3,649.40MM |
| Operating Income | $-919.20MM |
| Non-Operating Income | $-188.50MM |
| Interest Expense | $177.60MM |
| R&D Expense | $186.20MM |
| Income(Loss) | $-1,107.70MM |
| Taxes | $24.10MM |
| Profit(Loss)* | $-1,131.80MM |
| Stockholders Equity | $1,920.50MM |
| Inventory | $577.60MM |
| Assets | $5,769.30MM |
| Operating Cash Flow | $105.20MM |
| Capital expenditure | $188.20MM |
| Investing Cash Flow | $-192.70MM |
| Financing Cash Flow | $155.80MM |
| Earnings Per Share** | $-16.69 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.